207 related articles for article (PubMed ID: 11487732)
1. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.
Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
J Cereb Blood Flow Metab; 2001 Aug; 21(8):964-71. PubMed ID: 11487732
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.
Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M
J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
[TBL] [Abstract][Full Text] [Related]
4. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke.
Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Jiang P; Divine GW; Knight RA; Chopp M
J Cereb Blood Flow Metab; 2000 Jan; 20(1):21-7. PubMed ID: 10616789
[TBL] [Abstract][Full Text] [Related]
6. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
[TBL] [Abstract][Full Text] [Related]
7. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
[TBL] [Abstract][Full Text] [Related]
8. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke.
Yenari MA; de Crespigny A; Palmer JT; Roberts S; Schrier SL; Albers GW; Moseley ME; Steinberg GK
J Cereb Blood Flow Metab; 1997 Apr; 17(4):401-11. PubMed ID: 9143222
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
Ding G; Jiang Q; Zhang L; Zhang Z; Knight RA; Soltanian-Zadeh H; Lu M; Ewing JR; Li Q; Whitton PA; Chopp M
J Neurol Sci; 2004 Aug; 223(2):135-43. PubMed ID: 15337614
[TBL] [Abstract][Full Text] [Related]
10. Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain.
Neumann-Haefelin C; Brinker G; Uhlenküken U; Pillekamp F; Hossmann KA; Hoehn M
Stroke; 2002 May; 33(5):1392-8. PubMed ID: 11988620
[TBL] [Abstract][Full Text] [Related]
11. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
Yang Y; Li Q; Yang T; Hussain M; Shuaib A
J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
[TBL] [Abstract][Full Text] [Related]
12. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
13. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
[TBL] [Abstract][Full Text] [Related]
14. Monteplase reduces infarct volume and hemorrhagic transformation in rat model of embolic stroke.
Muramatsu H; Igarashi H; Okubo S; Katayama Y
Neurol Res; 2002 Apr; 24(3):311-6. PubMed ID: 11958428
[TBL] [Abstract][Full Text] [Related]
15. Prediction of hemorrhagic transformation following acute stroke: role of diffusion- and perfusion-weighted magnetic resonance imaging.
Tong DC; Adami A; Moseley ME; Marks MP
Arch Neurol; 2001 Apr; 58(4):587-93. PubMed ID: 11295989
[TBL] [Abstract][Full Text] [Related]
16. Combined X-ray angiography and diffusion-perfusion MRI for studying stroke evolution after rt-PA treatment in rats.
Busch E; Beaulieu C; de Crespigny A; Kreischer S; Diener HC; Moseley ME
Brain Res; 2002 Oct; 953(1-2):112-8. PubMed ID: 12384244
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
[TBL] [Abstract][Full Text] [Related]
18. Normobaric hyperoxia and delayed tPA treatment in a rat embolic stroke model.
Henninger N; Bratane BT; Bastan B; Bouley J; Fisher M
J Cereb Blood Flow Metab; 2009 Jan; 29(1):119-29. PubMed ID: 18766195
[TBL] [Abstract][Full Text] [Related]
19. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats.
Knight RA; Barker PB; Fagan SC; Li Y; Jacobs MA; Welch KM
Stroke; 1998 Jan; 29(1):144-51. PubMed ID: 9445344
[TBL] [Abstract][Full Text] [Related]
20. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
